Asia Dengue Voice and Action

What Asia Dengue Voice and Action does

Asia Dengue Voice and Action (ADVA) is a scientific working group dedicated to dengue vaccine advocacy in Asia, operating under the legal name Asia Dengue Voice and Action Group. The organization disseminates information and makes recommendations on dengue vaccine introduction strategies across the region, serving public health authorities and ministries of health, healthcare professionals and researchers, and the general public in dengue-endemic areas. ADVA convenes stakeholders through its annual Asia Dengue Summit series (now in its 9th iteration), pre-summit webinars, the World Dengue Day Forum, and the Dengue Slayers Challenge youth innovation competition co-organized with Junior Achievement. Its content portfolio includes the Asian Dengue Dashboard tracking regional dengue cases, the DengCast podcast, scientific publications and proceedings, and freely available educational materials covering dengue prevention, the Aedes mosquito life cycle, and vaccine awareness. The organization distributes all resources at no cost through its website (adva.asia), email newsletter, and social media channels (Facebook, X, Instagram, LinkedIn). As a non-profit scientific advocacy organization, ADVA does not sell products or services and operates without disclosed funding rounds, parent company, or commercial revenue model; its operating geographies span multiple countries across the Asia-Pacific region.

Name

Asia Dengue Voice and Action

Legal name

Asia Dengue Voice and Action Group

Website

https://adva.asia

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Asia Dengue Voice and Action (ADVA) is a non-profit scientific working group that advocates for dengue vaccine adoption in Asia by convening experts, publishing research, and disseminating educational resources to public health authorities, healthcare professionals, and the public.

Ownership category

akta.pro rank

Headquarters

HQ city

Wan Chai

HQ country

Hong Kong SAR China

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Marketing or Sales, Personnel, Technology or R&D

Distribution channels3 records

Marketing channels8 records

Core offering

Asia Dengue Voice and Action (ADVA) is a scientific working group that disseminates information and develops recommendations on dengue vaccine introduction strategies across Asia. It operates an integrated advocacy platform combining a regional dengue data dashboard, an annual Asia Dengue Summit conference, a podcast series, educational materials, and youth engagement programs aimed at advancing dengue prevention and vaccine adoption in Asian countries.

Product overview

Asia Dengue Voice and Action (ADVA) is a scientific working group dedicated to dengue vaccine advocacy in Asia. The organization operates as a single unified advocacy platform offering multiple interconnected services: the Asian Dengue Dashboard for tracking dengue data across the region, the annual Asia Dengue Summit as its flagship conference, the DengCast podcast for disseminating expert knowledge, educational materials on dengue prevention, publications and research papers supporting evidence-based advocacy, the Dengue Slayers Challenge youth innovation program, and pre-summit webinars. All these offerings serve the unified mission of disseminating information and making recommendations on dengue vaccine introduction strategies in Asia.

Differentiator

Problem solved

Functional benefit

Products and services

• Asian Dengue Dashboard A regional data dashboard tracking dengue cases and trends across Asia, with downloadable weekly spreadsheet updates for public health authorities, researchers, and the general public.
• Asia Dengue Summit Annual regional conference (running since at least the 5th edition) that brings together dengue experts, researchers, and healthcare professionals across Asia-Pacific to discuss dengue prevention, vaccination strategies, and the latest research findings.
• DengCast Podcast Podcast series covering dengue-related topics, featuring expert discussions, interviews, and content from the Asia Dengue Summit on dengue prevention and vaccine advocacy.
• Dengue Slayers Challenge Innovation and entrepreneurship competition for youth in Asia Pacific, organized in partnership with Junior Achievement, focused on dengue prevention solutions and awareness raising; Team WingWard won the 2024 Asia Pacific Grand Finals.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Junior Achievement (JA)coreStrategic or Co-development Partner · 1 January 2024ADVA partnered with Junior Achievement for the 'Dengue Slayers Challenge 2024 Asia Pacific Grand Finals,' a youth innovation competition encouraging innovation and entrepreneurship to address dengue. Team WingWard from Asia Pacific won the grand finals, demonstrating youth engagement in dengue prevention solutions.

Scale indicators2 records

Recent moves1 record

Expansion highlights4 records

Broad incumbents

• Gavi, the Vaccine Alliance: Public-private global health partnership that finances vaccine introduction in lower-income countries, including dengue-eligible Asian nations. Operates in the same vaccine introduction policy space as ADVA but at vastly larger scale and with direct government funding mechanisms.
• World Health Organization (WHO) Western Pacific Regional Office: WHO's regional office covering many of the same Asian countries ADVA targets, with authority over dengue prevention guidance and vaccine policy. Represents the dominant incumbent whose recommendations shape the environment in which ADVA's advocacy operates.
• PATH: Large global non-profit focused on health innovation, including vaccine introduction and disease surveillance across Asia. Overlaps with ADVA's mission on dengue and broader vaccine advocacy, but operates at much greater scale and across many disease areas.

Direct peers

• International Society for Infectious Diseases (ISID): International scientific society that promotes research, education, and communication on infectious diseases globally. Comparable to ADVA in its scientific convening role for infectious disease professionals, though operating at broader disease scope and global geographic reach.
• American Society of Tropical Medicine and Hygiene (ASTMH): Professional society supporting researchers, clinicians, and public health professionals in tropical medicine, including dengue. Comparable to ADVA as a scientific membership-style organization convening the tropical disease research community through events and publications.
• Sabin Vaccine Institute: U.S.-based non-profit that advances vaccine access, uptake, and innovation globally through advocacy and research. Comparable to ADVA in its vaccine advocacy mission and non-profit scientific working-group operating model.
• Coalition for Epidemic Preparedness Innovations (CEPI): Global partnership that finances and coordinates the development of vaccines against epidemic threats. Comparable to ADVA in its vaccine-focused advocacy mandate and multi-stakeholder convening model, though operating at global scale rather than Asia-specific.
• Drugs for Neglected Diseases Initiative (DNDi): International non-profit research organization developing new treatments for neglected patients, with regional offices in Asia. Comparable to ADVA as a disease-focused, advocacy-oriented non-profit working through scientific collaboration and stakeholder convening.
• Medicines for Malaria Venture (MMV): Swiss-based product development partnership working to discover, develop, and deliver new antimalarial drugs. Closely analogous in structure and mission to ADVA — a disease-specific non-profit advocacy/research organization targeting a major infectious disease prevalent in Asia.
• International Vaccine Institute (IVI): Seoul-headquartered international non-profit organization dedicated to vaccine research, development, and introduction, particularly for low- and middle-income countries. Highly comparable to ADVA as a non-profit, mission-driven scientific organization focused on vaccine advocacy and stakeholder convening in Asia.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/AdvaAsia
• Facebookfacebook.com/adva.asia
• LinkedInlinkedin.com/company/asia-dengue-voice-and-action-group
• Instagraminstagram.com/adva.asia

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asia Dengue Voice and Action